PrEP

handshake deal shake hand arrows ok yes
Favicon Fierce Pharma

Merck prepares expanded access to monthly PrEP pill early

Merck is launching the global access strategy before the phase 3 trial evaluating alimatravir for HIV PrEP has completed enrollment or produced data.
Angus Liu Jul 24, 2026 10:40am
Whale swimming in ocean seen from above

Merck wades deeper into HIV PrEP waters with pair of trials

Jul 14, 2025 1:12pm